View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Study - CLL13 - RVe - Rituximab 500 / Venetoclax 400, Chronic Lymphocytic Leukemia, Cycle 3-6
Protocol-ID: 1198 V1.0 (Mini), STUDY-CLL13-RVe-RITU500/VNTC400, CLL, C3-6Study protocol, available to authorized participants only.
Indication(s)
- Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma; ICD-10 C91.1-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 27.03.2019